Literature DB >> 9949218

Abnormalities in central nervous system development in osteogenesis imperfecta type II.

S C Emery1, N C Karpinski, L Hansen, E Masliah.   

Abstract

Osteogenesis imperfecta (OI) type II is a perinatally lethal condition resulting from mutations in type I collagen genes. In addition to characteristic skeletal anomalies, OI type II has recently been shown to be associated with neuropathological alterations, specifically perivenous microcalcifications, and impaired neuroblast migration. In light of these findings, and because type I collagen promotes neuritic maturation both in vitro and in vivo, we sought to determine if additional central nervous system (CNS) developmental anomalies could be found in previously autopsied OI type II cases, and if specific abnormalities correlate with OI subtypes. We retrospectively studied brains of nine patients diagnosed with OI. Of these, seven were OI type II: five were OI type IIA, one was type IIB, and one was type IIC. One OI type I specimen and one OI type III brain were included for comparison, as well as five controls. The IIC brain showed hippocampal malrotation, agyria, abnormal neuronal lamination, diffuse hemorrhage, and periventricular leukomalacia (PVL). The IIB brain had white matter gliosis, PVL, and perivascular calcifications, but was normally developed. Of the five type IIA brains, two showed migrational defects with coexisting PVL and gliosis, two were normally developed with similar white matter injuries, and one was grossly normal. These findings support the contention that collagen mutations might negatively impact CNS development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949218     DOI: 10.1007/s100249900100

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  7 in total

1.  Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Authors:  Jennifer A Anderton; Janet C Lindsey; Meryl E Lusher; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Neuro Oncol       Date:  2008-07-29       Impact factor: 12.300

2.  Incomplete inversion of the hippocampus--a common developmental anomaly.

Authors:  Dragan Bajic; Chen Wang; Eva Kumlien; Peter Mattsson; Staffan Lundberg; Orvar Eeg-Olofsson; Raili Raininko
Journal:  Eur Radiol       Date:  2007-09-09       Impact factor: 5.315

3.  Incomplete hippocampal inversion-is there a relation to epilepsy?

Authors:  Dragan Bajic; Eva Kumlien; Peter Mattsson; Staffan Lundberg; Chen Wang; Raili Raininko
Journal:  Eur Radiol       Date:  2009-05-14       Impact factor: 5.315

4.  Abnormalities in the cerebral arterial system in osteogenesis imperfecta.

Authors:  Sait Albayram; Osman Kizilkilic; Halit Yilmaz; Beyhan Tuysuz; Naci Kocer; Civan Islak
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

5.  Incomplete hippocampal inversion in schizophrenia: prevalence, severity, and impact on hippocampal structure.

Authors:  Maxwell J Roeske; Maureen McHugo; Simon Vandekar; Jennifer Urbano Blackford; Neil D Woodward; Stephan Heckers
Journal:  Mol Psychiatry       Date:  2021-01-12       Impact factor: 13.437

Review 6.  Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

Authors:  F S Van Dijk; D O Sillence
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

7.  Novel mutation of FKBP10 in a pediatric patient with osteogenesis imperfecta type XI identified by clinical exome sequencing.

Authors:  Harvy Mauricio Velasco; Jessica L Morales
Journal:  Appl Clin Genet       Date:  2017-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.